Insider · CIK 0001415537
Iwicki Mark T
Reports to the SEC for 10 companies · WALTHAM, MA
Transactions
50
Companies
10
Filings
5
CIK
0001415537
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-12 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-12 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-01-05 | IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-12-12 | MRUSMerus N.V.U Disposition from Tender | −$7.14M |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-12 | MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-12-09 | Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-10-23 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-10-23 | KALAKALA BIO, Inc.S Sale | −$125K |
| 2025-08-11 | Third Harmonic Bio, Inc.J Other | — |
| 2025-08-11 | Third Harmonic Bio, Inc.Stock OptionJ Other | — |
| 2025-06-24 | KALAKALA BIO, Inc.S Sale | −$53K |
| 2025-06-15 | KALAKALA BIO, Inc.A Award | — |
| 2025-06-15 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-03 | KALAKALA BIO, Inc.S Sale | +$40.6K |
| 2025-06-03 | KALAKALA BIO, Inc.S Sale | −$40.6K |
| 2025-06-03 | Akero Therapeutics, Inc.A Award | — |
| 2025-05-22 | MRUSMerus N.V. · Share Option (right to buy)A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-21 | IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-21 | IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-17 | IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-14 | IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-01-06 | KALAKALA BIO, Inc.S Sale | −$44.1K |
| 2025-01-06 | KALAKALA BIO, Inc.A Award | — |
| 2025-01-06 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-26 | KALAKALA BIO, Inc.S Sale | −$72K |
| 2024-06-08 | Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-06-06 | Third Harmonic Bio, Inc.Director Stock Option (right to buy)A Award | — |
| 2024-06-05 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4/AIwicki Mark T0001193125-26-310978SEC(opens sec.gov)
- 4Iwicki Mark T0001193125-26-272700SEC(opens sec.gov)
- 4Iwicki Mark T0001193125-26-006351SEC(opens sec.gov)
- 4Iwicki Mark T0001193125-25-317936SEC(opens sec.gov)
- 4Iwicki Mark T0001193125-25-312115SEC(opens sec.gov)
Companies
- Aimmune Therapeutics, Inc.Director
- Akero Therapeutics, Inc.Director
- Inhibikase Therapeutics, Inc.Director, Chief Executive OfficerIKT
- Jade Biosciences, Inc.DirectorJBIO
- KALA BIO, Inc.DirectorKALA
- Merus N.V.DirectorMRUS
- Pulmatrix, Inc.DirectorPULM
- Q32 Bio Inc.DirectorQTTB
- Sunovion Pharmaceuticals Inc.EVP & Chief Commercial Officer
- Third Harmonic Bio, Inc.Director
Address
Q32 BIO INC. 830 WINTER STREET
WALTHAM, MA, 02451